18项医疗器械需求、8.6亿元采购清单 成都高新区赴深圳寻找“合伙人”

Core Insights - The Chengdu High-tech Zone held a medical device industry cooperation seminar in Shenzhen, focusing on building connections between Chengdu and the Greater Bay Area through collaboration opportunities and policy interpretations [1] Group 1: Collaboration Opportunities - Chengdu High-tech Zone released a list of 18 key procurement demands totaling 860 million yuan, aimed at attracting high-quality support for local production of high-end medical devices [1] - The procurement list covers critical manufacturing aspects such as machined parts, biological raw materials, liquid pathways, optical components, PCBA, and sheet metal parts, providing clear market entry points for upstream suppliers [1] - The list emphasizes compliance with strict regulations and technical standards in the medical industry, highlighting strategic planning in three frontier areas for industrial ecological cooperation [1][2] Group 2: Industry Ecosystem Development - In the IVD (in vitro diagnostics) sector, the Chengdu High-tech Zone plans to build a full-chain ecosystem involving upstream supply chains, pilot testing, complete production, and clinical applications, leveraging resources from academic teams and industry associations [2] - The brain-machine industry ecosystem will focus on four key areas: brain-machine interfaces, neuroscience, psychological medicine, and robotics, in collaboration with renowned medical institutions and industry associations [2] - The digital health ecosystem will target areas such as Internet + healthcare, AI + precision medicine, and smart wearable devices, aiming to establish specialized technology platforms and research centers [2] Group 3: Policy Support and Incentives - The Chengdu High-tech Zone has introduced the "Circle Building and Chain Strengthening Development Policy" to support the medical device sector, offering up to 15 million yuan for individual projects and a total of 30 million yuan in rewards for companies [3] - The "Wutong Plan" was launched to provide a comprehensive service list covering the entire lifecycle of enterprises in the pharmaceutical and health industry, addressing common needs in R&D, clinical transformation, financing, and manufacturing [3]